| __timestamp | Agios Pharmaceuticals, Inc. | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 2287709 |
| Thursday, January 1, 2015 | 35992000 | 6844000 |
| Friday, January 1, 2016 | 50714000 | 8586000 |
| Sunday, January 1, 2017 | 71124000 | 6079000 |
| Monday, January 1, 2018 | 114145000 | 8362000 |
| Tuesday, January 1, 2019 | 132034000 | 9467000 |
| Wednesday, January 1, 2020 | 149070000 | 10899000 |
| Friday, January 1, 2021 | 121445000 | 14560000 |
| Saturday, January 1, 2022 | 121673000 | 17968000 |
| Sunday, January 1, 2023 | 119903000 | 22222000 |
| Monday, January 1, 2024 | 156784000 |
Cracking the code
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Agios Pharmaceuticals, Inc. consistently outspent Alpine Immune Sciences, Inc., with SG&A expenses peaking at approximately $149 million in 2020, a staggering 680% increase from 2014. In contrast, Alpine Immune Sciences, Inc. saw a more modest rise, with expenses growing nearly tenfold, reaching around $22 million in 2023. This disparity highlights Agios's aggressive investment in administrative and sales functions, possibly reflecting a broader market strategy. Meanwhile, Alpine's more conservative spending may indicate a focus on lean operations. Understanding these trends offers valuable insights into each company's strategic priorities and market positioning.
Breaking Down SG&A Expenses: Eli Lilly and Company vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Sanofi or Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Novavax, Inc.
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.